➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Dow
Merck
Boehringer Ingelheim
McKesson

Last Updated: March 7, 2021

DrugPatentWatch Database Preview

Drug Sales Trends for ADDERALL

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for ADDERALL (2018)

Revenues by Pharmacy Type

Pharmacy Type Revenues
$222,704,236
[disabled in preview] $0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
284,573
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $21,667,053
OTHER INSURANCE $65,001,159
[disabled in preview] $259,580,779
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for ADDERALL
Drug Units Sold Trends for ADDERALL

Annual Sales Revenues and Units Sold for ADDERALL

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
ADDERALL   Start Trial   Start Trial 2018
ADDERALL   Start Trial   Start Trial 2017
ADDERALL   Start Trial   Start Trial 2016
ADDERALL   Start Trial   Start Trial 2015
ADDERALL   Start Trial   Start Trial 2014
ADDERALL   Start Trial   Start Trial 2013
ADDERALL   Start Trial   Start Trial 2012
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Baxter
Moodys
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.